医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2014年
25期
176-177
,共2页
酶联免疫吸附法%安全输血%医疗纠纷%职业暴露
酶聯免疫吸附法%安全輸血%醫療糾紛%職業暴露
매련면역흡부법%안전수혈%의료규분%직업폭로
enzyme-linked immunosorbent assay (ELISA)%Safe blood transfusion%Medical malpractice%Occupational exposure
目的:回顾分析患者输血前血清学感染指标检测结果,提高医务人员的自我保护意识,降低职业暴露,减少医疗纠纷。方法对5049例患者输血前采用酶联免疫吸附法(ELISA)进行乙型肝炎病毒表面抗原(HBsAg)、丙肝肝炎病毒抗体(HCV)、梅毒螺旋体抗体(TP)、人类免疫缺陷病毒抗体(HIV)检测。结果感染率从高到低依次为HBsAg、TP、HIV、HCV,感染率分别为1.25%、1.11%、0.42%、0.26%,总阳性率为3.04%。结论患者输血前检测血清学感染性指标,避免和预防医院感染及交叉感染,加强医护人员的自我保护,减少因输血引起的医疗纠纷。
目的:迴顧分析患者輸血前血清學感染指標檢測結果,提高醫務人員的自我保護意識,降低職業暴露,減少醫療糾紛。方法對5049例患者輸血前採用酶聯免疫吸附法(ELISA)進行乙型肝炎病毒錶麵抗原(HBsAg)、丙肝肝炎病毒抗體(HCV)、梅毒螺鏇體抗體(TP)、人類免疫缺陷病毒抗體(HIV)檢測。結果感染率從高到低依次為HBsAg、TP、HIV、HCV,感染率分彆為1.25%、1.11%、0.42%、0.26%,總暘性率為3.04%。結論患者輸血前檢測血清學感染性指標,避免和預防醫院感染及交扠感染,加彊醫護人員的自我保護,減少因輸血引起的醫療糾紛。
목적:회고분석환자수혈전혈청학감염지표검측결과,제고의무인원적자아보호의식,강저직업폭로,감소의료규분。방법대5049례환자수혈전채용매련면역흡부법(ELISA)진행을형간염병독표면항원(HBsAg)、병간간염병독항체(HCV)、매독라선체항체(TP)、인류면역결함병독항체(HIV)검측。결과감염솔종고도저의차위HBsAg、TP、HIV、HCV,감염솔분별위1.25%、1.11%、0.42%、0.26%,총양성솔위3.04%。결론환자수혈전검측혈청학감염성지표,피면화예방의원감염급교차감염,가강의호인원적자아보호,감소인수혈인기적의료규분。
Objective Retrospective analysis of patients before blood transfusion infection indicators serological test results, to raise awareness of self-protection of medical personnel, reduce occupational exposure, reduce medical disputes.Method For patients with transfusion before 5049 cases by enzyme-linked immunosorbent assay (ELISA) for hepatitis B virus surface antigen (HBsAg), hepatitis C virus antibody (HCV), Treponema pal idum antibodies (TP), human immunodeficiency virus antibody (HIV) detection The results were analyzed.Results Infection rates in the order of HBsAg, TP, HIV, HCV, infection rates were 1.25%, 1.11%, 0.42%, 0.26%, 3.04% total positive rate. Conclusion Patients with pre-transfusion serological detection of infection targets, avoid and prevent hospital infection and cross-infection, strengthen health care workers to protect themselves and reduce medical disputes caused by blood transfusion.